| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.3 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |